Targeting mutant p53 in human tumors

J Clin Oncol. 2012 Oct 10;30(29):3648-50. doi: 10.1200/JCO.2012.44.0412. Epub 2012 Sep 10.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Molecular Targeted Therapy / methods
  • Mutation
  • Neoplasms / drug therapy*
  • Neoplasms / genetics*
  • Neoplasms / mortality
  • Patient Safety
  • Quinuclidines / therapeutic use*
  • Risk Assessment
  • Sensitivity and Specificity
  • Signal Transduction / drug effects
  • Survival Analysis
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / drug effects*
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • Antineoplastic Agents
  • Quinuclidines
  • Tumor Suppressor Protein p53
  • eprenetapopt